UPDATE : Monday, May 25, 2020
상단여백
Hanmi applies for market launch of Korea’s 1st new bio-drug by Lee Han-soo 2020-05-08 15:45
Arrest warrant sought for Sillajen’s CEO by Lee Han-soo 2020-05-08 15:43
Daewoong’s BTX sales growth offset by lawsuit expenses by Jeong Sae-im 2020-05-08 12:01
Abclon’s affibody neutralizes Covid-19 virus by Shim Hyun-tai 2020-05-07 18:50
ISU Abxis’ US partner gets EU patent for hemophilia B drug by Lee Han-soo 2020-05-07 11:22
라인
Daewoong confirms 99% cure rate in trial of gastric acid blocker by Lee Han-soo 2020-05-06 13:54
Anticipation for Korean BTX approval in China grows strong by Jeong Sae-im 2020-05-06 11:53
JW Pharma launches hemophilia A preventive drug in Korea by Lee Han-soo 2020-05-06 11:04
Huons to start trials for BTX in China by Lee Han-soo 2020-05-04 11:30
Boryung to be transformed into anticancer drugmaker by Jeong Sae-im 2020-05-04 10:37
라인
‘Kisqali can treat premenopausal breast cancer patients without removing ovaries’ by Shim Hyun-tai 2020-05-01 16:45
Korean drugmakers’ Q1 earnings rose despite Covid-19 by Jeong Sae-im 2020-05-01 14:45
Kolon to return $12.3 million upfront payment to Mundipharma by Jeong Sae-im 2020-05-01 11:23
GC’s Q1 profit surged amid Covid-19 by Shim Hyun-tai 2020-04-29 18:14
Court rejects Medytox’ request to stop administrative order on BTX suspension by Jeong Sae-im 2020-04-29 17:11
라인
‘Keytruda alone works as first-line therapy for lung cancer’ by Kim Yun-mi 2020-04-29 11:40
‘Pexa-Vec with immunotherapy reduced tumor in 75% of kidney cancer patients’ by Jeong Sae-im 2020-04-28 17:35
Genexine’s cervical cancer DNA vaccine boosts Keytruda’s response rate by Jeong Sae-im 2020-04-28 14:48
Researchers start testing pancreatitis drug to fight Covid-19 by Kim Yun-mi 2020-04-28 11:22
Genexine to present test results at US cancer academy by Shim Hyun-tai 2020-04-27 16:14
여백
여백
여백
Back to Top